Learn about FAAN's Grant Recipients

E-Mail Print Bookmark and Share

Research Grant Recipients

2011 Cycle

Simon G.A. Brown, M.D.
Western Australia Institute for Medical Research
Leukocyte signaling during human anaphylaxis

2009 Cycle

Stacie Jones, M.D.
Arkansas Children’s Hospital
Tree nut-specific immunotherapy for people who have multiple tree nut allergies

David Holdford, M.D.
Virginia Commonwealth University
Examination of the economic impact of food allergy and anaphylaxis in the U.S.

2008 Cycle

Carlos Camargo, M.D., Dr.P.H.
Massachusetts General Hospital
Prospective study of vitamin D in cord blood and risk of food allergy

Simon Hogan, Ph.D.
Cincinnati Children's Hospital Medical Center
Intestinal IL-9 and mast cells in food-induced anaphylaxis

Patrick Leung, Ph.D.
University of California-Davis
Mimotype vaccine against shrimp tropomyosin

Marc Rothenberg, M.D., Ph.D.
Cincinnati Children's Hospital Medical Center
The role of CREB binding protein (CBP) in eosinophilic esophagitis (EE)

Xiaoping Zhong, M.D., Ph.D.
Duke University Medical Center
Therapy for peanut-induced allergy and anaphylaxis

Daocheng Zhu, M.D., Ph.D.
Northwestern University - Evanston
Novel plant-human fusion proteins block peanut allergy

2007 Cycle

Kirsten Beyer, M.D.
Charité Universitätsmedizin Berlin
Primary prevention of hen’s egg allergy through early hen’s egg feeding

Mimi Tang, Ph.D.
Murdoch Childrens Research Institute
Probiotics and oral immunotherapy for the treatment of peanut allergy

Carla Bruijnzeel-Koomen, M.D., Ph.D.
University Medical Center Utrecht
Clinical relevance of peanut epitope recognition by IgE/IgG4 in adults

Donata Vercelli, M.D.
Arizona Board of Regents, University of Arizona
Impact of genetic factors on the natural history of food sensitization

2006 Cycle

Ke Zhang, M.D., Ph.D.
Regents of the University of California, Los Angeles
IgE-directed DNA vaccination for food (peanut) allergy immunotherapy 

Marc Rothenberg, M.D., Ph.D.
Cincinnati Children's Hospital Medical Center
Molecular analysis of eosinophilic esophagitis 

Randall Kopper, Ph.D.
Hendrix College  
Reduction of peanut anaphylaxis by treatment with activated charcoal 

Simon Brown, Ph.D.
University of Western Australia  
Mediators of human anaphylaxis 

2005 Cycle

Kirsten Beyer, M.D.
Charité Universitätsmedizin Berlin
Treatment of peanut allergy through specific oral tolerance induction

David Broide, M.B., Ch.B.
University of California, San Diego
Anti-Siglec F: A novel therapy for food allergy

Stephen Dreskin, M.D., Ph.D.
University of Colorado at Denver and Health Sciences Center
Peanut allergy: HLA and environment

Gideon Lack, M.D.
King’s College
In vitro evidence for cutaneous sensitization in peanut allergy

2004 Cycle

Wesley Burks, M.D.
Duke University
Oral peanut immunotherapy 

Wyatt Decker, M.D.
Mayo Clinic
The epidemiology and prehospital care of anaphylaxis in Olmsted County, MN
(Special Strategic Initiatives Grant)

Fred Finkelman, M.D.
University of Cincinnati Medical Center
Pathophysiology of local and systemic food allergy in a mouse model 

Chris Kepley, Ph.D.
Virginia Commonwealth University
Development of a peanut allergy model system to test therapeutic compounds

Marc E. Rothenberg, M.D., Ph.D.
Cincinnati Children’s Hospital Medical Center
Epidemiology and molecular classification of eosinophilic esophagitis (EE)